Glenmark Pharmaceuticals LimitedNSE: GLENMARK

Press Release Feb 09 2022

· Issued by Glenmark Pharmaceuticals Limited

Filed with NSE · · 4 pages · English

On 6ix: 6ix.com/news/press-release-feb-09-2022-10

Watch Glenmark Pharmaceuticals' latest callGlenmark Pharmaceuticals (NSE:GLENMARK) Q2 2026 Earnings Call · Replay · Nov 6

Release

Glenmark Pharmaceuticals Limited has informed the Exchange regarding a press release dated February 09, 2022, titled "Glenmark launches Nitric Oxide Nasal Spray (FabiSpray��) in India for the Treatment ofAdult Patients with COVID‐19 in partnership with SaNOtize".

Glenmark Pharmaceuticals Limited on 6ix

Earlier from Glenmark Pharmaceuticals

Later from Glenmark Pharmaceuticals

All Glenmark Pharmaceuticals news releases